In addition, TNFAIP6 is also an inflammatory mediator in several autoimmune diseases and cancers [52,53], atherosclerosis [54], acute pancreatitis [55], type‐1 diabetes [56], osteoarthritis [53], acute lung injury [57] and glioblastoma [58]. Here, TNFAIP6 is linked to cancer.